-
All patients had a single-level (L4-L5) surgery. There were statistical differences in age and the percentage of patients who experienced major comorbidities and osteoporosis between the two groups. The mean ages for the MIDLF and MI-TLIF groups were 68.7 ± 7.7 years and 57.7 ± 7.8 years, respectively (P < 0.001). The percentage of major comorbidities and osteoporosis for the MIDLF and MI-TLIF groups were 56.2% vs. 20.5% (P < 0.001) and 37.5% vs. 11.8% (P = 0.034), respectively. In the MIDLF group, 4 patients had spondylolisthesis, and 12 had degenerative disc disease with spinal stenosis, whereas in the MI-TLIF group, 8 patients had spondylolisthesis, and 22 had degenerative disc disease with spinal stenosis. The distribution of the disease etiology was not significantly different between the two groups (P > 0.05). No statistical differences regarding sex ratio, percentage of smokers, and BMI were observed between the groups (Table 1). Preoperative medical history, ODI, VAS back and leg pain, SF-36 PCS and MCS, HGB and HCT were similar between the groups. (Table 1).
Total Cases (n = 50) MIDLF (n = 16) MI-TLIF (n = 34) P-value Age (mean ± SD) 68.7 ± 7.7 57.7 ± 7.8 < 0.001 Sex ratio (F:M) 8:8 16:18 0.452 BMI (kg/m2, mean ± SD) 23.8 ± 2.5 24.7 ± 2.9 0.336 Smokers (n, %) 2, 13% 6, 17% 0.127 Major comorbidities (ischemic heart disease, diabetes, and hypertension) (n, %) 9, 56.2% 7, 20.50% < 0.001 Disease etiology Spondylolisthesis (n) 4 8 0.508 Degenerative disc disease with spinal stenosis (n) 12 22 0.461 Medical history (month) Back pain (mean ± SD) 41.3 ± 43.1 48.8 ± 73.7 0.708 Leg pain (mean ± SD) 49.3 ± 63.0 16.6 ± 24.4 0.061 Objective clinical outcome ODI (%) 65.1 ± 7.4 64.5 ± 11.1 0.862 VAS back pain (mean ± SD) 4.5 ± 1.7 5.5 ± 1.8 0.070 VAS leg pain (mean ± SD) 5.6 ± 1.0 6.0 ± 2.2 0.367 HGB-Pre (mean ± SD) 142.6 ± 10.3 144.0 ± 15.8 0.764 HCT-Pre (mean ± SD) 0.4 ± 0.03 0.4 ± 0.04 0.315 BMD (T < -2.5) (%) 37.50% 11.80% 0.034 SF-36 PCS (mean ± SD) 38.6 ± 7.8 36.4 ± 8.9 0.407 SF-36 MCS (mean ± SD) 47.8 ± 15.1 44.8 ± 15.7 0.534 Note. ODI, Oswestry Disability Index; VAS, visual analog scale; BMD, bone mineral density; MIDLF, midline lumbar fusion; MI-TLIF, minimally invasive transforaminal lumbar interbody fusion; SF-36, 36-Item Short-Form Health Survey; PCS, physical component score; MCS, mental component score. HGB, hemoglobin; HCT, hematocrit. Bold numbers indicate statistically significant differences (P < 0.05). Table 1. Preoperative comparison of the MIDLF and MI-TLIF groups
Table 2 reflects the perioperative comparison between the two groups. Operative time was significantly shorter for the MIDLF cases (MIDLF: 174 min, MI-TLIF: 229 min, P < 0.001). No statistical differences in blood loss, HGB of the first day after surgery [HGB(D1)], and total drainage volume were observed between both groups (P > 0.05). However, there was a lower HCT on the first day after surgery [HCT(D1)] in the MIDLF group (0.34 ± 0.02) than in the MI-TLIF (0.36 ± 0.04) group (P = 0.037). Hospitalization was shorter for the MIDLF cases (MIDLF: 2.5 d, MI-TLIF: 3.2 d, P = 0.056); however, the difference was not statistically significant. One patient in the MI-TLIF group (2.9%, 1 of 34 patients) required blood transfusion postoperatively, whereas none of the patients in the MIDLF group required transfusion (P = 0.331).
Variables MIDLF (n = 16) MI-TLIF (n = 34) P-value Operative time (min) 174.3 ± 27.9 229.4 ± 50.0 < 0.001 Blood loss (mL) 69.3 ± 36.7 82.5 ± 59.2 0.343 HGB (D1) 118.1 ± 8.1 122.7 ± 16.6 0.202 HCT (D1) 0.34 ± 0.02 0.36 ± 0.04 0.037 Total drainage volume (mL) 156.0 ± 92.0 223.3 ± 238.3 0.161 Hospitalization (days) 2.5 ± 0.8 3.2 ± 1.9 0.056 No. of transfusion (n) 0 1 0.331 Note. MIDLF, midline lumbar fusion; MI-TLIF, minimally invasive transforaminal lumbar interbody fusion; HGB, hemoglobin; HCT, hematocrit. Bold numbers indicate statistically significant values (P < 0.05). Table 2. Perioperative comparison of the MIDLF and MI-TLIF groups
Table 3 reflects the comparison of postoperative recovery between the groups. Postoperatively, both MIDLF and MI-TLIF groups showed significant improvement in ODI, VAS back and leg pain, and SF-36 PCS and MCS. However, significant differences were observed between the two groups in the abovementioned five parameters at the 3 months follow-up (P < 0.05). At the 6 months follow-up, VAS leg pain scores (1.3 ± 0.8 vs. 0.5 ± 1.1, P = 0.018) and SF-36 PCS (59.1 ± 8.8 vs. 63.2 ± 6.5, P = 0.007) were worse in the MIDLF group than in the MI-TLIF group. No statistical differences were observed between the groups at the 12 months follow-up (P > 0.05). At the 24 months follow-up, VAS back pain scores and SF-36 PCS were worse in the MI-TLIF group than in the MIDLF group (0.8 ± 0.8 vs. 1.7 ± 1.1, P = 0.018 and 66.8 ± 5.1 vs. 62.0 ± 9.7, P = 0.027, respectively). Clinical results at each time point between the groups are shown in Figure 3.
Clinical Outcomes MIDLF MI-TLIF P-value 3 month ODI 19.0 ± 6.1 14.2 ± 10.3 0.047 VAS back pain 2.4 ± 0.6 1.5 ± 1.0 0.001 VAS leg pain 2.0 ±1.2 0.9 ± 1.1 0.005 SF-36 PCS 55.3 ± 12.2 62.1 ± 10.3 0.046 SF-36 MCS 57.5 ± 10.6 64.1 ± 8.3 0.021 6 month ODI 12.2 ± 6.7 10.1 ± 10.7 0.469 VAS back pain 1.5 ± 1.0 0.9 ± 0.9 0.055 VAS leg pain 1.3 ± 0.8 0.5 ± 1.1 0.018 SF-36 PCS 59.1 ± 8.8 63.2 ± 6.5 0.007 SF-36 MCS 61.2 ± 11.7 63.6 ± 12.6 0.522 12 month ODI 7.2 ± 6.1 6.9 ± 9.5 0.915 VAS back pain 1.0 ± 0.9 0.9 ± 0.9 0.605 VAS leg pain 0.8 ± 0.8 0.5 ± 1.0 0.303 SF-36 PCS 64.1 ± 7.4 64.8 ± 5.7 0.704 SF-36 MCS 65.3 ± 9.7 68.6 ± 8.3 0.215 24 month ODI 4.8 ± 3.2 6.5 ± 7.1 0.26 VAS back pain 0.8 ± 0.8 1.7 ± 1.5 0.018 VAS leg pain 0.6 ± 0.7 1.2 ± 1.8 0.116 SF-36 PCS 66.8 ± 5.1 62.0 ± 9.7 0.027 SF-36 MCS 66.5 ± 8.3 66.1 ± 8.5 0.881 Note. ODI, Oswestry Disability Index; VAS, visual analog scale; MIDLF, midline lumbar fusion; MI-TLIF, minimally invasive transforaminal lumbar interbody fusion; SF-36, 36-Item Short-Form Health Survey; PCS, physical component score; MCS, mental component score; mo, months. Bold values indicate statistically significant values (P < 0.05). Table 3. Comparison of clinical outcomes between the MIDLF and MI-TLIF groups
The majority in the MIDLF and MI-TLIF groups (94% vs. 88%) managed to achieve grade 1 fusion at minimal 2 years of follow-up. The MIDLF group had slightly better fusion grades at 6, 12, and 24 months follow-up; however, this was not statistically significant (Table 4).
Bridwell Grade 1 Fusion MIDLF (%) MI-TLIF (%) P 6 month 62 53 0.525 12 month 94 85 0.391 24 month 94 88 0.544 Note. MIDLF, midline lumbar fusion; MI-TLIF, minimally invasive transforaminal lumbar interbody fusion. Table 4. Fusion rates of the MIDLF and MI-TLIF groups (%)
-
Eleven perioperative complications were recorded in the MI-TLIF group. Approach-related complications (interbody migration and neurologic deficit in one patient; dura tear and adjacent segmental disease in one patient, respectively; nonunion, four patients) were evident in eight patients. Other minor complications, including superficial wound infection, urinary tract infection, and anemia (one each), were transient (less than1 week) in 10 of 34 patients, representing a complication rate of 29.4%. There was one case of symptomatic cage migration with neurologic deficit (6 months postoperatively) that was surgically revised. There was one case of durotomy which did not need repair. There were four cases of nonunion (Grade 2, Bridwell classification) with low back pain during the last follow-up (average, 25 months), aggravated by the weight-bearing or a significant level of activity; however, they did not experience sciatic radiating pain, and their daily activity and work were not affected. All four cases were managed conservatively.
On the contrary, five perioperative complications were recorded in the MIDLF group. Approach-related complications (screw malposition, neurologic deficit, epidural hematoma, one patient; wound infection and nonunion in one patient, respectively) were evident in 3 of 16 patients, representing a complication rate of 18.75% (3/16). Revision surgery was performed for one case. The right foot dropped immediately after the operation, and the malposition of the right L4 screw and epidural hematoma were confirmed during revision exploration. The CBT screws on the right sides were replaced by the pedicle screws. There was one case of nonunion (Grade 2, Bridwell classification) with mild low back pain at 12 months follow-up. The clinical manifestation was similar to those cases in the MI-TLIF group and was managed conservatively.
The overall complication rate was not significantly different between the groups (18.75% vs. 29.4%, P = 0.423).
Two-Year Outcomes of Midline lumbar Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in the Treatment of L4-L5 Degenerative Disease
doi: 10.3967/bes2020.114
- Received Date: 2020-06-29
- Accepted Date: 2020-10-10
-
Key words:
- Minimally invasive techniques /
- Cortical bone trajectory /
- Clinical outcomes /
- Midline lumbar fusion /
- Transforaminal lumbar interbody fusion
Abstract:
Citation: | WU Feng Liang, DANG Lei, ZHOU Hua, YU Miao, WEI Feng, JIANG Liang, LIU Zhong Jun, LIU Xiao Guang. Two-Year Outcomes of Midline lumbar Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in the Treatment of L4-L5 Degenerative Disease[J]. Biomedical and Environmental Sciences, 2020, 33(11): 839-848. doi: 10.3967/bes2020.114 |